Muscle quality is associated with function, frailty and survival in interstitial lung disease

Background Sarcopenia is associated with adverse outcomes in interstitial lung disease (ILD). Bioelectrical impedance-derived phase angle (PhA) offers a repeatable measure of muscle quality, with lower PhA associated with greater frailty. Whether PhA is associated with clinical outcomes in ILD after accounting for muscle mass remains unknown. Methods In a prospective multicentre cohort study of 364 adults with ILD, PhA was assessed against sarcopenia-related domains. Mutually adjusted associations of PhA and appendicular skeletal muscle index (ASMI) with concurrent % predicted forced vital capacity (%FVC), 6-min walk distance (6MWD) and frailty, as well as longitudinal waitlist delisting or death, were evaluated using serial linear, logistic and Cox regression, as appropriate. Results After adjusting for ASMI, each 1- sd worsening in PhA was associated with lower %FVC (−2.9%, 95% CI −5.0– −0.7) and shorter 6MWD (−28.9 m, 95% CI −44.5– −13.4). Worsening PhA was associated with increased odds of frailty by Short Physical Performance Battery (OR 1.8, 95% CI 1.3–2.5) and Fried Frailty Phenotype (OR 1.8, 95% CI 1.2–2.7) and risk of waitlist delisting or death (hazard ratio (HR) 2.0, 95% CI 1.2–3.1). After adjusting for PhA, associations between ASMI and outcomes other than pulmonary function were no longer statistically significant. Conclusions Poor muscle quality, rather than muscle mass alone, may be an important risk factor for worse functional outcomes and survival in ILD. PhA provides a scalable measure of muscle quality in clinical and research settings and may identify patients at higher risk of functional decline and death.

Authors

Institutions

Publication Details

Journal
ERJ Open Research
Published
2026-11-19
DOI
https://doi.org/10.1183/23120541.01502-2026
Primary Topic
Nutrition and Health in Aging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Muscle quality is associated with function, frailty and survival in interstitial lung disease

Jasleen Kukreja, Daniel R. Calabrese, Legna Betancourt, JESSICA JOHNSON et al.
ERJ Open Research
Nutrition and Health in Aging
article

Muscle quality is associated with function, frailty and survival in interstitial lung disease

Jasleen Kukreja, Daniel R. Calabrese, Legna Betancourt, JESSICA JOHNSON, Steven R. Hays, Paul J. Wolters, John R. Greenland, Jonathan Paul Singer, Kenneth E. Covinsky, Michelle L. Oyster, Selim M. Arcasoy, A. Curnow, Chiung-Yu Huang, Aida E. Venado, Michaela Restivo Anderson, Jason D. Christie, Anya Sriram, Hunter Scott, Paige Gambetta, Luke J. Benvenuto, Ying Gao, Shreena Patel
article en

Abstract

Background Sarcopenia is associated with adverse outcomes in interstitial lung disease (ILD). Bioelectrical impedance-derived phase angle (PhA) offers a repeatable measure of muscle quality, with lower PhA associated with greater frailty. Whether PhA is associated with clinical outcomes in ILD after accounting for muscle mass remains unknown. Methods In a prospective multicentre cohort study of 364 adults with ILD, PhA was assessed against sarcopenia-related domains. Mutually adjusted associations of PhA and appendicular skeletal muscle index (ASMI) with concurrent % predicted forced vital capacity (%FVC), 6-min walk distance (6MWD) and frailty, as well as longitudinal waitlist delisting or death, were evaluated using serial linear, logistic and Cox regression, as appropriate. Results After adjusting for ASMI, each 1- sd worsening in PhA was associated with lower %FVC (−2.9%, 95% CI −5.0– −0.7) and shorter 6MWD (−28.9 m, 95% CI −44.5– −13.4). Worsening PhA was associated with increased odds of frailty by Short Physical Performance Battery (OR 1.8, 95% CI 1.3–2.5) and Fried Frailty Phenotype (OR 1.8, 95% CI 1.2–2.7) and risk of waitlist delisting or death (hazard ratio (HR) 2.0, 95% CI 1.2–3.1). After adjusting for PhA, associations between ASMI and outcomes other than pulmonary function were no longer statistically significant. Conclusions Poor muscle quality, rather than muscle mass alone, may be an important risk factor for worse functional outcomes and survival in ILD. PhA provides a scalable measure of muscle quality in clinical and research settings and may identify patients at higher risk of functional decline and death.

ERJ Open Research
University of California, San Francisco (US), Columbia University Irving Medical Center (US), University of Pennsylvania (US)
Nutrition and Health in Aging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon